- ￥460 - 1610
- Solarbio|ActivAb
- 北京
- CLP0437
- 2025年07月29日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
Store at -20℃，2 years.(Avoid freeze/thaw cycles)
- 保质期：
Store at -20℃，2 years.(Avoid freeze/thaw cycles)
- 英文名：
NS4A-NS4B Hepatitis Virus C
- 库存：
现询
- 供应商：
北京索莱宝科技有限公司
- 规格：
10mg/5mg/1mg
| 规格： | 10mg | 产品价格： | ￥1610.0 |
|---|---|---|---|
| 规格： | 5mg | 产品价格： | ￥1150.0 |
| 规格： | 1mg | 产品价格： | ￥460.0 |
| 基本信息 | |
| 产品类型 | 多肽 |
| CAS | No.484-43-5 |
| 单字母序列 | DRVYVHPFHL |
| 三字母序列 | Asp-Arg-Val-Tyr-Val-His-Pro-Phe-His-Leu |
| 分子式 | C61H87N17O14 |
| 分子量 | 1282.45 |
| 纯度 | ≥95% |
| 外观(性状) | 冻干粉;Lyophilized powder |
| 盐体系 | TFA盐;Trifluoroacetate salt |
| 来源 | 合成;Synthetic |
| 储存条件 | Store at -20℃，2 years.(Avoid freeze/thaw cycles) |
| 类别/标签 | 激素和相关肽（Hormone and Related Peptides） |
| 规格 | 5-Valine-angiotensin I 是血管紧张素 I 的 Ang1 肽，促肌肉收缩，能够用于肾素-血管紧张素系统的研究。Aangiotensin I 被认为是一种神经递质。它是 Aangiotensin II 和 Aangiotensin 片段 1-7 的前体，这两种激素参与调节体液量和醛固酮的释放。 |
| In Vitro | 5-Valine-angiotensin I shows myotropic effect (muscle contraction) on isolated rat colon after nonspecific desensitization of receptors with acetylcholine. |
| 单位 | 瓶 |
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Hepatitis C Virus: Types, Subtypes, and Beyond
Non-A, non-B hepatitis was recognized as a frequent consequence of blood transfusion for many years before the agent responsible, hepatitis C virus (HCV), was first cloned and sequenced in 1989 Very quickly it became apparent
Detection and Typing of Hepatitis C Virus
For more than two decades prior to the discovery of the hepatitis C virus (HCV), posttransfusion non-A, non-B (NANB) hepatitis was thought to have a viral etiology. In 1989, the virus was finally identified through a unique application
Nomenclature and Numbering of the Hepatitis C Virus
International standardization and coordination of the nomenclature of variants of hepatitis C virus (HCV) is increasingly needed as more is discovered about the scale of HCV-related liver disease and important biological and antigenic
技术资料暂无技术资料 索取技术资料
